UNFO Med

Company Overview

Snapshot

Founded in July 2010 by Dr. Izak Daizade, UNFO Med operates with 1–10 employees. The company has developed a patented Universal Neonatal Foot Orthotics (UNFO) device, receiving FDA approval in the United States and CE mark approval in Europe.

Business overview

UNFO Med develops medical devices within the Health Tech & Life Sciences sector, focusing on neonatal care. Its core product is the Universal Neonatal Foot Orthotics (UNFO) device, a non-invasive corrective foot brace designed for the effective and safe treatment of metatarsus adductus (MTA) in newborns. This technology addresses challenges associated with traditional casting and stretching methods for MTA and clubfoot. The company serves markets including the United States, Europe, Ukraine, South Korea, Brazil, South Africa, India, Canada, and Australia, targeting patients, parents, children, and insurance companies.

Strategic signal

In June 2026, UNFO Med announced a strategic partnership with OrthoPediatrics to introduce its non-invasive foot brace for newborns to the US market. This collaboration signals a significant expansion opportunity for UNFO Med, leveraging OrthoPediatrics' established presence to enhance market penetration and accessibility for its specialized neonatal orthotics, validating the product's clinical utility and commercial potential.

Company Intelligence Q&A

What is UNFO Med's primary product?

UNFO Med develops the Universal Neonatal Foot Orthotics (UNFO) device, a child-friendly corrective foot brace for treating metatarsus adductus (MTA) in newborns.

When was UNFO Med founded and by whom?

UNFO Med was founded in July 2010 by Dr. Izak Daizade.

Has UNFO Med received regulatory approvals for its product?

Yes, UNFO Med has received FDA approval in the United States and CE mark approval in Europe for its UNFO device.

What was a significant recent partnership for UNFO Med?

In June 2026, UNFO Med partnered with OrthoPediatrics to bring its non-invasive foot brace for newborns to the US market.

In which international markets does UNFO Med operate?

UNFO Med has clients and operates in Israel, Italy, Ukraine, South Korea, the United States, Europe, Brazil, South Africa, India, Canada, and Australia.